Shefali Vyas

497 citations
16 papers · 366 indexed · h-index 8

Impact in

    • Renal Transplantation Outcomes and Treatments
  • Nephrology top 5%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes

Papers in

Shefali Vyas

14 papers receiving 354 citations

Peers

Shefali Vyas
Comparison fields: 5 of 54
  • Transplantation 125
  • Nephrology 92
  • Hepatology 39
  • Oncology 127
  • Surgery 94
Replace Delphine Morel with:
Delphine Morel France
Y Kadotani Japan
Michael Duerr Germany
Kiyohide Toki Japan
Xiang He China
J. Strehlau Germany
Smaragdi Marinaki Greece
Bogdan Obrișcă Romania
Bogdan Sorohan Romania
Virginia de la Orden Spain
Shefali Vyas relative to Delphine Morel France Delphine Morel's profile →
Citations per field
00.5×12×
Delphine Morel · 1×
Citations per year

Countries citing papers authored by Shefali Vyas

Since Specialization
Citations

This map shows the geographic impact of Shefali Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shefali Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shefali Vyas more than expected).

Fields of papers citing papers by Shefali Vyas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shefali Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shefali Vyas. The network helps show where Shefali Vyas may publish in the future.

Co-authors

The 25 scholars most cited alongside Shefali Vyas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shefali Vyas Line = papers co-authored together Shefali Vyas links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20250
2 20240
3 20241
4 20232
5 20162
6 20163
7 20156
8 201213
9 201111
10 201047
11 20089
12 20075
13 200411
14 2003214
15 200120
16 199922

About Shefali Vyas

Shefali Vyas is a scholar working on Transplantation, Nephrology, Dermatology, Rehabilitation and Pharmacy, having authored 16 papers that have together received 366 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Dermatology and Skin Diseases (4 papers), Complement system in diseases (3 papers), Neurological Complications and Syndromes (2 papers), Organ Donation and Transplantation (2 papers), Exercise and Physiological Responses (2 papers) and Pregnancy and Medication Impact (2 papers). The work is most often cited by research in Transplantation (125 citations), Nephrology (92 citations), Hepatology (39 citations), Oncology (127 citations) and Surgery (94 citations). Shefali Vyas has collaborated with scholars based in United States, Denmark and Germany. Frequent co-authors include Isabel Roberti, Baogui Li, Hua Yang, Manikkam Suthanthiran, Vijay K. Sharma, Mary A. Maluccio, Noosha Baqi, Anup Singh, Guillermo Hidalgo and Stuart Geffner. Their work appears in journals such as Pediatric Transplantation, Transplantation, Pediatric Nephrology, British Journal of Dermatology and Dermatology and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026